drugset / Trial / NCT06837155
A QT/QTc Evaluation Study of TS-172 in Healthy Adult Subjects
RandomizedCrossoverQuadruple-blindTreatment
Summary
A clinical study to evaluate the effects on QT/QTc interval of TS-172 in healthy adults subjects
Timeline
- Start
- 2025-03-03
- Primary completion
- 2025-05-20
- Completion
- 2025-05-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Moxifloxacin | Small molecule | 400 mg | Oral |
| Subject | TS-172 | Unknown | 20 mg | Oral |
| Subject | TS-172 | Unknown | 90 mg | Oral |
Indications
No indication recorded.